Ciprofloxacin HCl-loaded calcium carbonate nanoparticles: preparation, solid state characterization, and evaluation of antimicrobial effect against Staphylococcus aureus
Source abstract
Abstract
Ciprofloxacin HCl-loaded calcium carbonate (CaCO3) nanoparticles were prepared via a w/o microemulsion method and characterized by dynamic light scattering, scanning electron microscopy, X-ray powder diffraction (XRPD) analysis, differential scanning calorimetry (DSC), and Fourier transform infrared spectroscopy (FTIR). The in vitro drug release profiles as well as antimicrobial effect against Staphylococcus aureus (S. aureus) were also evaluated. The antibacterial effect was studied using serial dilution technique to determine the minimum inhibitory concentration (MIC) of the nanoparticles and was confirmed by streak cultures. The mean particle size, drug loading and entrapment efficiency were calculated to be 116.09 nm, 20.49% and 44.05%, respectively. PXRD and FTIR studies confirmed that both vaterite and calcite polymorphs of CaCO3 were formed during the preparation process. In vitro release profiles of the nanoparticles showed slow release pattern for 12 h. The drug-loaded nanoparticles showed similar MICs against S. aureus compared to untreated drug. However, a preserved antimicrobial effect was observed for drug-loaded nanoparticles compared to untreated drug after 2 days of incubation.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Antimicrobial agents and applications · Calcium Carbonate Crystallization and Inhibition · Energetic Materials and Combustion
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Research Center for Pharmaceutical Nanotechnology, Tabriz University of Medical Sciences, Tabriz, Iran;
Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran;
Hematology and Oncology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran;
Faculty of Pharmacy, Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
References (73)
Show source-provided references
1. Adams K · Clin Orthopaed Rel Res · 1992 · 278 · 24410.1097/00003086-199205000-00037 ↗
2. Adibkia K · Afr J Pharm Pharmacol · 2012 · 6 · 941
3. 10.1016/j.colsurfb.2010.11.01410.1016/j.colsurfb.2010.11.014 ↗
4. 10.3109/10717544.2012.74640210.3109/10717544.2012.746402 ↗
5. 10.1586/eri.11.12110.1586/eri.11.121 ↗
6. 10.1016/j.jcrysgro.2004.09.09010.1016/j.jcrysgro.2004.09.090 ↗
7. Barzegar-Jalali M. · Int J Pharm · 1990 · 63 · R910.1016/0378-5173(90)90171-Y ↗
8. 10.18433/J3D59T10.18433/J3D59T ↗
9. 10.18433/J3JG6110.18433/J3JG61 ↗
10. 10.1007/s00264005019510.1007/s002640050195 ↗
11. Berne BJ · 2000
12. 10.3109/21691401.2013.84887410.3109/21691401.2013.848874 ↗
13. 10.14227/DT120205P2310.14227/DT120205P23 ↗
14. 10.1097/00005373-200001000-0003710.1097/00005373-200001000-00037 ↗
15. Brunton LL. · 2011
16. 10.1080/0265204070147258410.1080/02652040701472584 ↗
17. 10.1016/j.powtec.2008.06.00410.1016/j.powtec.2008.06.004 ↗
18. 10.1007/978-1-60327-198-1_610.1007/978-1-60327-198-1_6 ↗
19. Cooper J, Hunt J. 2006. The significance of zeta potential in osteogenesis. Annual Meeting in conjunction with the 25th International Biomaterials Symposium. p. 592.
20. Darvishi B · Iran J Pharm Res · 2014 · 14 · 373
21. 10.1016/j.ijpharm.2006.01.04110.1016/j.ijpharm.2006.01.041 ↗
22. 10.1016/j.ijpharm.2004.01.03310.1016/j.ijpharm.2004.01.033 ↗
23. 10.1517/17425247.2015.104953010.1517/17425247.2015.1049530 ↗
24. 10.3109/21691401.2015.104210810.3109/21691401.2015.1042108 ↗
25. 10.1016/j.msec.2014.08.03110.1016/j.msec.2014.08.031 ↗
26. Dizaj SM · Adv Pharm Bull · 2015 · 5 · 19
27. Drlica K · . Microbiol Mol Biol Rev · 1997 · 61 · 37710.1128/.61.3.377-392.1997 ↗
28. 10.3109/21691401.2016.114745410.3109/21691401.2016.1147454 ↗
29. 10.1016/j.nano.2007.03.00310.1016/j.nano.2007.03.003 ↗
30. 10.2165/00003495-200059060-0000310.2165/00003495-200059060-00003 ↗
31. 10.1016/S0142-9612(00)00170-810.1016/S0142-9612(00)00170-8 ↗
32. 10.1089/15209150376381640910.1089/152091503763816409 ↗
33. 10.1166/jnn.2010.283210.1166/jnn.2010.2832 ↗
34. Honary S · Trop J Pharm Res · 2013 · 12 · 265
35. 10.1016/j.colsurfb.2014.09.01910.1016/j.colsurfb.2014.09.019 ↗
36. 10.3109/21691401.2015.111123310.3109/21691401.2015.1111233 ↗
37. 10.1186/s40580-014-0031-510.1186/s40580-014-0031-5 ↗
38. 10.1016/j.ijpharm.2007.11.00110.1016/j.ijpharm.2007.11.001 ↗
39. Kadivar A · PLoS One · 2015 · 10 · e012687410.1371/journal.pone.0126874 ↗
40. Kalam M · Cont J Pharm Sci · 2007 · 1 · 30
41. 10.3390/molecules18091058010.3390/molecules180910580 ↗
42. Kesavan K · DARU · 2010 · 18 · 237
43. Kirboga S · Chem Eng · 2013 · 32 · 2119
44. 10.1002/jbm.a.3076610.1002/jbm.a.30766 ↗
45. 10.1002/1097-4636(200105)55:2<217::AID-JBM1008>3.0.CO;2-Y10.1002/1097-4636(200105)55:2<217::AID-JBM1008>3.0.CO;2-Y ↗
46. 10.1002/jps.2308710.1002/jps.23087 ↗
47. 10.1016/S1466-6049(00)00058-110.1016/S1466-6049(00)00058-1 ↗
48. 10.1016/j.jconrel.2005.08.01310.1016/j.jconrel.2005.08.013 ↗
49. 10.3109/10837450.2013.83629310.3109/10837450.2013.836293 ↗
50. Montaseri H · Iran J Pharm Res · 2010 · 1 · 21
51. 10.1016/S0142-9612(02)00614-210.1016/S0142-9612(02)00614-2 ↗
52. 10.1002/sia.290410.1002/sia.2904 ↗
53. 10.5772/3104510.5772/31045 ↗
54. Ofoefule S · 2002 · 94
55. Perry CR · Clin Orthopaedic Relat Res · 1985 · 192 · 284
56. 10.1007/s00604-010-0523-x10.1007/s00604-010-0523-x ↗
57. 10.1155/2015/79460110.1155/2015/794601 ↗
58. 10.4103/2231-4040.8554110.4103/2231-4040.85541 ↗
59. 10.5772/5842310.5772/58423 ↗
60. 10.1016/j.msea.2006.08.10510.1016/j.msea.2006.08.105 ↗
61. Silverstein RM · 2014
62. 10.1186/1746-160X-5-1310.1186/1746-160X-5-13 ↗
63. 10.1097/00005131-199902000-0000610.1097/00005131-199902000-00006 ↗
64. 10.1016/j.ces.2008.04.02210.1016/j.ces.2008.04.022 ↗
65. 10.1177/0022034501080010120110.1177/00220345010800101201 ↗
66. 10.1016/j.jconrel.2004.11.01510.1016/j.jconrel.2004.11.015 ↗
67. 10.1016/j.powtec.2006.10.04610.1016/j.powtec.2006.10.046 ↗
68. 10.1016/j.jcis.2008.09.04510.1016/j.jcis.2008.09.045 ↗
69. 10.1016/j.msec.2014.01.00810.1016/j.msec.2014.01.008 ↗
70. 10.1093/infdis/158.4.83110.1093/infdis/158.4.831 ↗
71. 10.1056/NEJM19700205282060610.1056/NEJM197002052820606 ↗
72. 10.1016/j.jcis.2010.08.06010.1016/j.jcis.2010.08.060 ↗
73. 10.2174/09298671079041629010.2174/092986710790416290 ↗